Category: Policy & Legislation
Saturday Links – 21 February 2026
- CBO on the Democrat’s IRA bill: “Part D spending per beneficiary in 2035 is now projected to be more than $4,000, up from less than $3,000 in the January 2025 baseline.”
- Another CBO report: What cuts in Medicaid?
- Pressure has real effects on an athlete’s body.
- The case for statins.
- What an increasing number of patients want from their therapists: extra time on their tests of permission to keep a pet. (WSJ)
Friday Links – 20 February 2026
- “By 2036, interest costs, Social Security, Medicare, and Medicaid are projected to consume 100 percent of federal revenues.” (All of these are on autopilot.)
- Last year, the US may have recorded the lowest murder rate in its 250-year history.
- Global spending on climate change now equals $16 trillion.
- Cassidy on the FDA: Companies report that they face a “reviewer lottery,” where critical questions hinge on the approach of a small number of individuals at FDA…. This uncertainty dampens investment and increases the time it takes for patients to receive new therapies.
- Nearly half of all adults have high blood pressure.
Why Most Drugs Should be Sold Over the Counter
FDA Commissioner Marty Makary recently stated that when it comes to drugs that currently require a prescription, “everything should be over the counter” unless they are unsafe or need monitoring. This post explains why that’s good.